Pregnane X Receptor and its Potential Role in Drug Resistance in Cancer Treatment

E-ISSN： 2212-3970|4|1|19-27

ISSN： 1574-8928

Source： Recent Patents on Anti-Cancer Drug Discovery, Vol.4, Iss.1, 2009-01, pp. : 19-27

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of pregnane X receptor expression on drug resistance in breast cancer

By Qiao EnQi Yang HongJian

Oncology Letters, Vol. 7, Iss. 4, 2014-04 ,pp. : 1191-1196

Spandidos Publications

Access to resources Recommend Favorite

Downregulation of transient receptor potential cation channel, subfamily C, member 1 contributes to drug resistance and high histological grade in ovarian cancer

By Liu Xia Zou Jing Su Jie Lu Yi Zhang Jian Li Li Yin Fuqiang

International Journal of Oncology, Vol. 48, Iss. 1, 2016-01 ,pp. : 243-252

Spandidos Publications

Access to resources Recommend Favorite

TRAIL-receptor antibodies as a potential cancer treatment

By Buchsbaum Donald J Forero-Torres Andres LoBuglio Albert F

Future Oncology, Vol. 3, Iss. 4, 2007-08 ,pp. : 405-409

Future Medicine

Access to resources Recommend Favorite

Polymorphisms of the nuclear receptor pregnane X receptor and organic anion transporter polypeptides 1A2, 1B1, 1B3, and 2B1 are not associated with breast cancer risk

By Justenhoven Christina

Breast Cancer Research and Treatment, Vol. 125, Iss. 2, 2011-01 ,pp. : 563-569

Springer Publishing Company

Access to resources Recommend Favorite

Functional characteristics of cancer stem cells and their role in drug resistance of prostate cancer

International Journal of Oncology, Vol. 45, Iss. 3, 2014-01 ,pp. : 985-994

Spandidos Publications

Access to resources Recommend Favorite